Login Register Cart 0
Generic placeholder image

Current Pharmaceutical Biotechnology

Editor-in-Chief

ISSN (Print): 1389-2010
ISSN (Online): 1873-4316

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Preface

Suicide Gene Therapy: A New Frontier for Cancer Fighting

Author(s): Davide Prosperi and Miriam Colombo

Volume 20, Issue 1, 2019

Page: [2 - 4] Pages: 3

DOI: 10.2174/138920102001190306102136

« Previous Next »
[1]
Tannock, I.F. Conventional cancer therapy: Promise broken or promise delayed? Lancet, 1998, 351, SII9-SII16.
[2]
Amer, H. Gene therapy for cancer: Present status and future perspective. Mol. Cell. Ther., 2014, 2, 1-19.
[3]
Ginn, S.; Amaya, A.K.; Alexander, I.E.; Edelstein, M.; Abedi, M.R. Gene therapy clinical trials worldwide to 2017: An update. J. Gene Med., 2018, 20, 5.
[4]
Navarro, S.; Carrillo, E.; Griñán-Lisón, C.; Martín, A.; Perán, M.; Marchal, J.A.; Boulaiz, H. Cancer suicide gene therapy: A patent review. Expert Opin. Ther. Pat., 2016, 26, 1095-1104.
[5]
Vago, R.; Collico, V.; Zuppone, S.; Prosperi, D.; Colombo, M. Nanoparticle-mediated delivery of suicide genes in cancer therapy. Pharmacol. Res., 2016, 111, 619-641.
[6]
Karjoo, Z.; Chen, X.; Hatefi, A. Progress and problems with the use of suicide genes for targeted cancer therapy. Adv. Drug Deliv. Rev., 2016, 1, 113-128.
[7]
Chen, C.; Yue, D.; Lei, L.; Wang, H.; Lu, J.; Zhou, Y.; Liu, S.; Ding, T.; Guo, M.; Xu, L. Promoter-operating targeted expression of gene therapy in cancer: Current stage and prospect. Mol. Ther. Nucleic Acids, 2018, 11, 508-514.
[8]
Hill, A.; Chen, M.; Chen, C.K.; Pfeifer, B.A.; Jones, C.H. Overcoming gene-delivery hurdles: Physiological considerations for nonviral vectors. Trends Biotechnol., 2016, 34, 91-105.
[9]
Thomas, C.; Ehrhardt, A.; Kay, M.A. Progress and problems with the use of viral vectors for gene therapy. Nat. Rev. Genet., 2003, 4, 346-358.
[10]
Yin, H.; Kanasty, R.L.; Eltoukhy, A.A.; Vegas, A.J.; Dorkin, J.R.; Anderson, D.G. Non-viral vectors for gene-based therapy. Nat. Rev. Genet., 2014, 15, 541-555.
[11]
Senapati, S.; Mahanta, A.K.; Kumar, S.; Maiti, P. Controlled drug delivery vehicles for cancer treatment and their performance. Signal Transduct. Target. Ther., 2018, 3, 1-19.

Rights & Permissions Print Cite
Article Metrics
35
7
© 2024 Bentham Science Publishers | Privacy Policy